Charles River has the proven experience, range of services and expertise to help you successfully initiate and complete critical phases of preclinical drug development by designing, performing and documenting safety tests that meet the appropriate regulatory requirements before and after clinical trials begin. Our scientific and regulatory staff are committed to providing exactly what you need with flexible solutions, accelerated timelines and customized approaches. For your IND-enabling program proposal, click here.
Charles River’s preclinical newsletter, the Researcher, contains detailed information designed to support your research. These publications are now available online through our information portal, The Source℠.
To register for The Source℠, please click here.
Already registered? Please click here to login.